Policy

‘Govt taking steps to reduce dependence on import of antibiotic raw materials’

PTI New Delhi | Updated on February 11, 2020

The quantity of raw materials imported for the formulation of antibiotic medicines was reduced to 11,230.50 tonnes in 2019, as the government has undertaken various steps to promote the production in the country, the Lok Sabha was informed on Tuesday.

As per the information received from the port offices of the Central Drugs Standard Control Organisation (CDSCO), it stood at 12,006.11 tonnes for 2018 and 5,591.44 tonnes in 2017, Minister of Chemicals & Fertilizers DV Sadananda Gowda said, in a reply in the House.

Fillip to domestic manufacturers

“The policies formulated by the Government from time to time are designed to minimise country’s dependence on imports and to give fillip to indigenous manufacturing,” he added.

In this direction, the government has withdrawn exemption of Customs duty on certain categories of bulk drugs/APIs, which are used in the manufacturing of some of the antibiotics, to provide a level-playing field to domestic manufacturers, Gowda said.

The Department of Pharmaceuticals has formulated a scheme, namely ‘‘Assistance to bulk drug industry for common facility centre’’, for providing assistance to bulk drug segment in any upcoming bulk drug park promoted by state governments/state corporations, he added.

“An inter-ministerial task force was also constituted under the chairmanship of the Minister of State of Chemicals and Fertilizers on April 18, 2018 to formulate a roadmap for enhanced production of active pharmaceutical ingredients (APIs) in the country,” Gowda said.

Ministry of health and family welfare and CDSCO have also various measures to encourage indigenous manufacturing of drugs, he added.

Published on February 11, 2020

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like